The effects of L-thyroxin replacement therapy on bone minerals and body composition in hypothyroid children

INTRODUCTION: Prolonged treatment with levothyroxine 4 (L-T4) is a well known risk factor for osteoporosis. Patients on L-T4 replacement occasionally have a subnormal TSH, which carries a risk of development of bone loss. Thyroid hormones directly affect bone cells, stimulating osteoclastic and oste...

Descripción completa

Detalles Bibliográficos
Autores principales: Salama, Hassan M., El-Dayem, Soha A., Yousef, Hala, Fawzy, Ashraf, Abou-Ismail, Laila, El-lebedy, Dalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2010
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282520/
https://www.ncbi.nlm.nih.gov/pubmed/22371779
http://dx.doi.org/10.5114/aoms.2010.14264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282520/
https://www.ncbi.nlm.nih.gov/pubmed/22371779
http://dx.doi.org/10.5114/aoms.2010.14264

Ejemplares similares